So happy that they decided last year to drop the Chemotherapy arm and run this as a pure Checkpoint inhibitor trial.
With everything going on I think I missed the key significant point that this 1B extension is going into checkpoint naive patients.
This will be massive if results like the complete response already mentioned are delivered in this expansion aswell.
Great new hires brought on board today, which any other company would have marked as price sensitive as well.
Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-47
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $357.0M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $977.7K | 20.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3232340 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 854027 | 4 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |